AT536175T
Compositions and their uses for lysosomal enzyme deficiencies
Abstract
The present invention provides a therapeutic delivery system comprising an extracted yeast cell wall comprising beta-glucana payload trapping molecule and a payload molecule, wherein the payload molecule and the payload trapping molecule are soluble in the same solvent system wherein the payload molecule supplements the function of the deficient lysosomal enzyme. The invention further provides methods of making and methods of using the therapeutic delivery system.
Term
Term ended
Expired 19 September 2025, 1 year ago.
- Priority
- Filed
- Granted
- Expired
- Today
48 members in 16 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 61087204 | United States of America | P | |
| 2005033300 | United States of America | W |
Members48
| Document | Office | Kind | |
|---|---|---|---|
| US2005281781A1 | United States of America | A1 | |
| CA2570313A1 | Canada | A1 | |
| WO2006007372A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2005284727A1 | Australia | A1 | |
| CA2580537A1 | Canada | A1 | |
| WO2006032039A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US2006083718A1 | United States of America | A1 | |
| WO2006007372A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1755567A2 | European Patent Office (EPO) | A2 | |
| WO2006032039A3 | World Intellectual Property Organization (WIPO) | A3 | |
| MXPA06014552A | Mexico | A | |
| KR20070054246A | Republic of Korea | A | |
| EP1802289A2 | European Patent Office (EPO) | A2 | |
| CN101001615A | China | A | |
| CN101052383A | China | A | |
| BRPI0512068A | Brazil | A | |
| JP2008503472A | Japan | A | |
| HK1105587A | Hong Kong, China | A | |
| HK1105587A1 | Hong Kong, China | A1 | |
| IL181748A0 | Israel | A0 | |
| IL181748D0 | Israel | D0 | |
| JP2008513484A | Japan | A | |
| BRPI0515332A | Brazil | A | |
| ZA200701943B | South Africa | B | |
| US7740861B2 | United States of America | B2 | |
| US2010221357A1 | United States of America | A1 | |
| EP1755567B1 | European Patent Office (EPO) | B1 | |
| AT486590T | Austria | T | |
| ATE486590T1 | Austria | T1 | |
| DE602005024547D1 | Germany | D1 | |
| ES2355916T3 | Spain | T3 | |
| US8007814B2 | United States of America | B2 | |
| EP1802289B1 | European Patent Office (EPO) | B1 | |
| AT536175TThis record | Austria | T | |
| ATE536175T1 | Austria | T1 | |
| US2012039929A1 | United States of America | A1 | |
| ES2375995T3 | Spain | T3 | |
| CN101001615B | China | B | |
| CN101052383B | China | B | |
| JP5197005B2 | Japan | B2 | |
| CA2570313C | Canada | C | |
| JP5302537B2 | Japan | B2 | |
| US8580275B2 | United States of America | B2 | |
| IL181748A | Israel | A | |
| US8637045B2 | United States of America | B2 | |
| US2014335047A1 | United States of America | A1 | |
| CA2580537C | Canada | C | |
| US9682135B2 | United States of America | B2 |
Numbers
- Application
- 5814893
Titles2
- German
- ZUSAMMENSETZUNGEN UND IHRE VERWENDUNGEN BEI LYSOSOMALEN ENZYMSTÖRUNGEN
- English
- COMPOSITIONS AND ITS USE IN LYSOSOMAL ENZYME DISORDER
Classification
- CPC, 8
- A61K9/5068
- A61K48/00
- A61K47/6901
- A61K48/0008
- A61K48/0041
- A61P3/00
- A61P43/00
- A61K31/716
- IPC, 1
- A61K9 50